Comment on Jaki et al., A proposal for a new PhD level curriculum on quantitative methods for drug development. Pharmaceutical Statistics 17 (5):593–606, Sep/Oct 2018, DOI: 10.1002/pst.1873

ASA Special Interest Group on Statistics and Pharmacometrics/ASA Special Interest Group on Statistics and Pharmacometrics (SIG SxP)

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)278-281
Number of pages4
JournalPharmaceutical Statistics
Volume18
Issue number3
DOIs
StatePublished - May 1 2019

ASJC Scopus subject areas

  • Statistics and Probability
  • Pharmacology
  • Pharmacology (medical)

Cite this